beta 2-Microglobulin amyloidosis: effect of ESRF treatment modality and dialysis membrane type
- PMID: 8804017
- DOI: 10.1093/ndt/11.supp2.147
beta 2-Microglobulin amyloidosis: effect of ESRF treatment modality and dialysis membrane type
Similar articles
-
Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.Clin Nephrol. 1994 Jul;42 Suppl 1:S52-6. Clin Nephrol. 1994. PMID: 7923985 Review. No abstract available.
-
[Amyloidosis of the dialysis patient].Bull Mem Acad R Med Belg. 1988;143(10-12):456-65; discussion 465-7. Bull Mem Acad R Med Belg. 1988. PMID: 3077074 French. No abstract available.
-
[Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].Postepy Hig Med Dosw. 1992;46(2):209-38. Postepy Hig Med Dosw. 1992. PMID: 1470582 Review. Polish.
-
beta 2-microglobulin and amyloidosis: who is at risk?Nephrol Dial Transplant. 1995;10 Suppl 10:48-51. Nephrol Dial Transplant. 1995. PMID: 8825433 Review. No abstract available.
-
Dialysis-related amyloidosis and high-flux membranes.Contrib Nephrol. 1992;96:124-37. doi: 10.1159/000421129. Contrib Nephrol. 1992. PMID: 1740047 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials